BG108381A - Имидазотриазинонови производни и тяхното използване срещу възпалителни процеси и/или болести на имунната система - Google Patents

Имидазотриазинонови производни и тяхното използване срещу възпалителни процеси и/или болести на имунната система Download PDF

Info

Publication number
BG108381A
BG108381A BG108381A BG10838103A BG108381A BG 108381 A BG108381 A BG 108381A BG 108381 A BG108381 A BG 108381A BG 10838103 A BG10838103 A BG 10838103A BG 108381 A BG108381 A BG 108381A
Authority
BG
Bulgaria
Prior art keywords
mmol
compounds
yield
triazin
nmr
Prior art date
Application number
BG108381A
Other languages
Bulgarian (bg)
English (en)
Inventor
Cristina Alonso-Alija
Heike Gielen
Martin Hendrix
Ulrich Niewoehner
Dagmar Schauss
Hilmar Bischoff
Nils Burkhardt
Volker Geiss
Karl - Heinz Schlemmer
Nigel Cuthbert
Mary Fitzgerald
Graham Sturton
Original Assignee
Bayer Aktiensegellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiensegellschaft filed Critical Bayer Aktiensegellschaft
Publication of BG108381A publication Critical patent/BG108381A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG108381A 2001-06-01 2003-11-24 Имидазотриазинонови производни и тяхното използване срещу възпалителни процеси и/или болести на имунната система BG108381A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3

Publications (1)

Publication Number Publication Date
BG108381A true BG108381A (bg) 2004-11-30

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108381A BG108381A (bg) 2001-06-01 2003-11-24 Имидазотриазинонови производни и тяхното използване срещу възпалителни процеси и/или болести на имунната система

Country Status (28)

Country Link
US (2) US7115602B2 (es)
EP (1) EP1399447A1 (es)
JP (1) JP2004536078A (es)
KR (1) KR20040023605A (es)
CN (1) CN1512993A (es)
BG (1) BG108381A (es)
BR (1) BR0210910A (es)
CA (1) CA2449095A1 (es)
CO (1) CO5540381A2 (es)
CZ (1) CZ295609B6 (es)
EC (1) ECSP034872A (es)
EE (1) EE200300570A (es)
GB (1) GB0113344D0 (es)
GT (1) GT200200099A (es)
HR (1) HRP20031090A2 (es)
HU (1) HUP0400773A3 (es)
MX (1) MXPA03010985A (es)
NO (1) NO20035324L (es)
NZ (1) NZ529848A (es)
PE (1) PE20030231A1 (es)
PL (1) PL366906A1 (es)
RU (1) RU2003138078A (es)
SK (1) SK14672003A3 (es)
SV (1) SV2003001061A (es)
UA (1) UA75149C2 (es)
UY (1) UY27312A1 (es)
WO (1) WO2002098879A1 (es)
ZA (1) ZA200309111B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するイミダゾトリアジノン誘導体
TW200745106A (en) * 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
EP2685983B1 (en) * 2011-03-17 2016-05-18 Algiax Pharmaceuticals GmbH Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
WO2015144598A1 (en) * 2014-03-28 2015-10-01 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (da) 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
EP2295436A1 (de) * 1997-11-12 2011-03-16 Bayer Schering Pharma AG 2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase V Inhibitoren
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CA2323008C (en) * 1999-10-11 2005-07-12 Pfizer Inc. Pharmaceutically active compounds

Also Published As

Publication number Publication date
NO20035324D0 (no) 2003-11-28
NO20035324L (no) 2003-11-28
MXPA03010985A (es) 2004-10-28
US20050065153A1 (en) 2005-03-24
GT200200099A (es) 2003-02-13
BR0210910A (pt) 2004-06-08
US20030139415A1 (en) 2003-07-24
CA2449095A1 (en) 2002-12-12
CO5540381A2 (es) 2005-07-29
GB0113344D0 (en) 2001-07-25
EE200300570A (et) 2004-04-15
CZ20033275A3 (en) 2004-03-17
UA75149C2 (en) 2006-03-15
JP2004536078A (ja) 2004-12-02
HUP0400773A3 (en) 2007-09-28
SK14672003A3 (sk) 2004-08-03
ZA200309111B (en) 2004-11-24
EP1399447A1 (en) 2004-03-24
CN1512993A (zh) 2004-07-14
PL366906A1 (en) 2005-02-07
UY27312A1 (es) 2003-02-28
US7115602B2 (en) 2006-10-03
HUP0400773A2 (hu) 2004-07-28
KR20040023605A (ko) 2004-03-18
RU2003138078A (ru) 2005-05-27
ECSP034872A (es) 2004-01-28
PE20030231A1 (es) 2003-05-16
WO2002098879A1 (en) 2002-12-12
SV2003001061A (es) 2003-03-18
HRP20031090A2 (en) 2005-08-31
CZ295609B6 (cs) 2005-08-17
NZ529848A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
JP7208240B2 (ja) Lpaアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
CA2692859C (en) Imidazo-, pyrazolopyrazines and imidazotriazines and their use
EP1689751B1 (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activity
US20040152739A1 (en) Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
JP2010168405A (ja) 新規チアゾロピリミジン化合物
KR20020038941A (ko) 포스포디에스테라아제 억제제로서의5-(2-치환된-5-헤테로사이클릴설포닐피리드-3-일)-디하이드로피라졸로[4,3-d]피리미딘-7-온
WO2006108489A1 (en) Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
PT1697370E (pt) Heterociclos azabicíclicos como moduladores do receptor de canabinóides
MX2014008158A (es) Compuestos de piridazina-amida.
JP2005530801A (ja) 5−エチルイミダゾトリアジノン類
JP2005507390A (ja) ケモカインレセプター活性調節因子としてのプテリジノン誘導体
BG108381A (bg) Имидазотриазинонови производни и тяхното използване срещу възпалителни процеси и/или болести на имунната система
JP2007509123A (ja) キナーゼ阻害剤としてのチエノ−ピリジノン誘導体
EP1397363B1 (en) 5-ethyl-imidazotriazinones
JP2005531550A (ja) ホスホジエステラーゼ阻害剤としての5−エチル−イミダゾ(5,1−f)(1,2,4)トリアジン−4(3h)−オン
EP1966213A1 (en) Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
JP2004536815A (ja) 2−ヘテロアリール−イミダゾトリアジノンおよび炎症性または免疫性疾患の治療におけるその使用
AU2002344351A1 (en) Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
JP2005534630A (ja) 7−アミノイミダゾトリアゾン類